Recommendations on COVID-19 vaccination CoNaIn agrees on primary schedules 6 months to 3 years once authorized by National Administration of Medicines, Food and Medical Technology’(ANMAT) CoNaIn agrees to heterologous reinforcement schedules in children aged 3 and 4 years. Consensus meetings are recommended with the different scientific societies regarding vaccination of minors against COVID.

Equalization of the age of vaccination against HPV for girls and boys, defining vaccination between 9 and 14 years of age. Extension of HPV vaccination up to 45 years of age for immunocompromised male patients.

Countries are encouraged to: Focus on routine immunization of the children under 5 years of age Conduct targeted community campaigns (district by district) Use retired nurses and the private sector to support the EPI Team Conduct targeted campaigns for catch-up of HPV vaccine